KYMR · Kymera Therapeutics, Inc. · Investor Relations
$115.31
-4.08 (-3.42%)
At close · Nov 20
Return incl. dividend (before tax)
Q3 2026 earnings call transcript
Market Cap
$9.84B
Shares
85.37M
Volume · Nov 20
1.28M
Avg daily vol (3M)
847.26K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-11-23 13:00 UTC | Kymera Therapeutics KT-621 BROADEN2 Phase 2b Atopic Dermatitis Trial Results | Earnings call |
Recent news
Past events
Source: https://investors.kymeratx.com/
Key facts
CIK
1815442
CUSIP
501575104
13F (30d)
320 filings
293 filers
Visit website
Investor relations